Severe acute pancreatitis: surgical indications and treatment.
Langenbecks Arch Surg
; 406(3): 521-535, 2021 May.
Article
in En
| MEDLINE
| ID: mdl-32910276
ABSTRACT
BACKGROUND:
Acute pancreatitis (AP) is defined as an acute inflammatory attack of the pancreas of sudden onset. Around 25% of patients have either moderately severe or severe disease with a mortality rate of 15-20%.PURPOSE:
The aim of this article was to summarize the advances being made in the understanding of this disease and the important role of surgery. RESULTS ANDCONCLUSIONS:
An accurate diagnosis should be made a soon as possible, initiating resuscitation with large volume intravenous fluids and oxygen by mask. Predicted severe disease will require intensive monitoring. Most deaths within the first week are due to multi-organ failure; thus, these patients will require intensive therapy unit management. During the second phase of the disease, death is due to local complications arising from the pancreatic inflammation, requiring accurate identification to determine the correct form of treatment. Acute peripancreatic fluid collections arise < 4 weeks after onset of interstitial edematous pancreatitis, not requiring any treatment. Most pancreatic pseudocysts arise > 4 weeks and largely resolve on conservative management. Necrotizing pancreatitis causing acute necrotic collections and later walled-off necrosis will require treatment if symptomatic or infected. Initial endoscopic transgastric or percutaneous drainage will resolve less serious collections but necrosectomy using minimally invasive approaches will be needed for more serious collections. To prevent recurrent attacks of AP, causative factors need to be removed where possible such as cholecystectomy and cessation of alcohol. Future progress requires improved management of multi-organ failure and more effective minimally invasive techniques for the removal of necrosis.Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pancreatitis, Acute Necrotizing
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Langenbecks Arch Surg
Year:
2021
Type:
Article
Affiliation country:
Germany